Ocugen, Inc. Receives Positive Scientific Advice From the EMA for Ocu410ST Gene Therapy for Stargardt Disease
Ocugen’s ongoing Phase 2/3 GARDian3 trial for Stargardt disease has received a positive opinion from the EMA’s Committee for...
eClinical Tech News
Cognition Therapeutics and FDA Align on Zervimesine Trial for Alzheimer’s
Cognition Therapeutics received positive feedback from the FDA regarding its Phase 3 trial design for zervimesine (CT1812) in mild-to-moderate...
FDA Approves Tiziana’s Phase 2 Trial for Multiple System Atrophy
Tiziana Life SciencesLife Sciences has received FDA clearance for a Phase 2a trial of intranasal foralumab in patients with...
io Bio Cylembio® Phase 3 Trial Shows Clinical Improvement, Narrowly Misses Significance
IO Biotech’s Phase 3 trial of Cylembio plus pembrolizumab in advanced melanoma narrowly missed statistical significance on its primary...
Forx Therapeutics Launches First-in-Human Trial of Novel Anti-Cancer Drug Forx-428
FoRx Therapeutics has dosed the first patient in a Phase 1 trial of FORX-428, an oral PARG inhibitor, in...
FDA Accepts Arvinas’s New Drug Application for Advanced Breast Cancer Treatment
The FDA accepted Arvinas and Pfizer’s New Drug Application (NDA) for vepdegestrant, an oral PROTAC estrogen receptor degrader, for...
Paragonix LiverGuard System Reduces Post-Transplant Complications
A propensity-matched analysis of 410 liver transplant patients from the GUARDIAN-Liver Registry showed a 51% reduction in early allograft...
Poltreg Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes
PolTREG has dosed the first patient in a Phase 2 trial of PTG-007, an autologous cell therapy for pre-symptomatic...
Sonnet Biotherapeutics Expands Ovarian Cancer Dose Escalation Trial
Sonnet BioTherapeutics reports two out of three patients with platinum-resistant ovarian cancer (PROC) achieved a partial response (PR) in...
Clearmind Medicine Gets IRB Approval for Alcohol Use Disorder Trial
Clearmind Medicine has received Institutional Review Board (IRB) approval from Hadassah Medical Center in Jerusalem for its ongoing Phase...